Table 2.
Health-economic and treatment cost parameters
| Parameter | |
| Total LOS, days | |
| Median (range) | 25 (1–252) |
| Mean (95% CI) | 34.06 (31.74–36.39) |
| ICU LOS, days | |
| Median (range) | 15 (1–203) |
| Mean (95% CI) | 22.33 (20.07–24.58) |
| Mechanical ventilation when affected, h | |
| Median (range) | 227 (1–1412) |
| Mean (95% CI) | 303.84 (265.34–342.33) |
| Total treatment costs, EURa | |
| Median (range) | 22 819.66 (527.12–514 297.45) |
| Mean (95% CI) | 39 427.16 (35 440.74–43 413.59) |
| Sensitivity analysis of total treatment costs with different discount rates, EUR | |
| 0%, median (range) | 25 330.91 (629.41–561 986.71) |
| 5%, median (range) | 21 071.91 (496.68–485 465.25) |
| 10%, median (range) | 17 906.25 (355.29–422 228.93) |
| Case-mix index, points | |
| Median (range) | 5.225 (0.192–123.654) |
| Mean (95% CI) | 8.853 (8.012–9.693) |
| Candidiasis indication with ICD-10 code, n (%) | |
| B37.0 (Candidal stomatitis) | 256 (35.36) |
| B37.1 (Pulmonary candidiasis) | 76 (10.50) |
| B37.2 (Candidiasis of skin and nail) | 26 (3.59) |
| B37.3 (Candidiasis of vulva and vagina) | 23 (3.18) |
| B37.4 (Candidiasis of other urogenital sites) | 59 (8.15) |
| B37.5 (Candidal meningitis) | 3 (0.41) |
| B37.6 (Candidal endocarditis) | 0 (0.00) |
| B37.7 (Candidal sepsis/candidaemia) | 45 (6.22) |
| B37.81 (Candidal oesophagitis) | 108 (14.92) |
| B37.88 (Candidiasis of other sites) | 124 (17.13) |
| B37.9 (Candidiasis, unspecified) | 4 (0.55) |
a
Adjusted to inflation to the year 2022 by 3% discount rate as recommended by the German Institute for Quality and Cost Effectiveness in the Health Care Sector (IQWiG).